Elon, Inc.
Neuralink's First Patient Speaks, and How to Invest in SpaceX
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Last week, Bloomberg Businessweek published an exclusive look at Noland Arbaugh, the first person to get Elon Musk’s Neuralink technology implanted in his head. Our own Ashlee Vance spent time with Arbaugh, who lives with his parents and (as you’ll hear) some vocal farm animals. Vance joins us to talk about what he learned from the first patient in Neuralink’s inaugural clinical trial. He is joined by Bloomberg’s Sarah McBride to give a full picture on what it all means. Plus, we talk to markets reporter Kiel Porter and space reporter Loren Grush about all of the action around SpaceX stock—which is kind of interesting since it’s still a private company.
See omnystudio.com/listener for privacy information.